retatrutide clinical trial safety Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide for weight loss: Study

Perez-Garcia A, Hurtado-Carneiro V, Herrero-De-Dios C, Dongil P, Garcia-Maurino JE, Sanchez MD, et al

Most injection site reactions are not true allergies

GLP-1 receptor agonists have become some of the most prescribed medications in Australia

If a product hides its formulator, skips third-party testing, or buries doses in a proprietary blend, treat its claims with skepticism

This is still an area of active research, but heres what were learningand what were seeing in real patients: GLP-1s Might Help Lower Chronic Cortisol Some studies suggest these medications might help bring down high cortisol levelsespecially in people with insulin resistance or prediabetes